Extra-large 3.2mm channel allows excellent suction with EndoTherapy devices in place.
Slim bronchoscope designed for paediatric applications.
...erformance fiberoptic imaging from the latest 60 s...ts fiberscope range, focussing on providing clinic...ge performance. Olympus has a impressive range of ...n the respiratory tract to meet the demands of inc...
Indications For Usage: , Thoracic surgery. , Broncho-spirometry. , Thoracoscopies. , Differential or selective lung ventilation.
Medicine Products:(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3...logist and author of the study said that they have...in aim of the cure is to prevent the immune system...n the pancreas. There is a window of time and the ...e and the mice do not suffer from the disease. ...
...with alcohol use, yet may not be seeking help, war...idden populations// may need specialist services t...veral ethnic minorities have higher levels of alco... than the general population, writes Rahul Rao of ...
... in enclosed public places will be activated. Scot...dies// in the world that will probe the impact of ..., budgeted at a mammoth ?140,000, will be funded b...ducted by Aberdeen University researchers, who wil...
...m government health officials and the World Health...d// of H5N1 bird flu. She is the virus’ first huma...on. The girl, Mon Puthy, had been in close proxi... village in Kampong Speu province about 40 miles w...
Other Medicine News:Health News:Type 1 diabetes has a cure? 2(Date:9/4/2008)... activity and favorable safety ...- Idenix,Pharmaceuticals, I...engaged,in the discovery and development of drugs ...ous diseases, today announced that it has complete...non-nucleoside reverse,transcriptase inhibitor (NN...
(Date:9/3/2008)...Call/ -- Simcere,Pharmaceutical Group (NYSE: SCR ...generic pharmaceuticals and manufacturer of the pa...n as Endostar) in China,announced the interim res...uest of the SFDA, Simcere initiated a Phase IV cli...rapeutic efficacy of Endu, a modified,version of r...
(Date:9/3/2008)...- Panacea Pharmaceuticals,Inc. today announced th...g,antibodies against human aspartyl (asparaginyl) ...r biomarker and therapeutic target. These antibodi...husetts Institute of,Technology (MIT) and Panacea ... development of human cancer diagnostics and thera...
(Date:9/3/2008)...Study in Subjects with ALS, RICHMOND, Calif., Sep..., Inc. (Nasdaq: SGMO ) announced today that it ha...evaluate its drug, SB-509, in subjects,with ALS, a...r which there,are limited treatment options and no...formulation of a plasmid,encoding a zinc finger DN...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib 28ZACTIMA 28R 29 29 in Non Small Cell Lung C 3903 1AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib 28ZACTIMA 28R 29 29 in Non Small Cell Lung C 3903 2AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib 28ZACTIMA 28R 29 29 in Non Small Cell Lung C 3903 3Omnicell Announces Completion of Its Common Stock Repurchase Plan 14121 1Omnicell Announces Completion of Its Common Stock Repurchase Plan 14121 2Chef LaLa to Provide Healthy Menu Makeovers 14117 1Chef LaLa to Provide Healthy Menu Makeovers 14117 2Chef LaLa to Provide Healthy Menu Makeovers 14117 3Chef LaLa to Provide Healthy Menu Makeovers 14117 4Chef LaLa to Provide Healthy Menu Makeovers 14117 5Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast 3899 1Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast 3899 2... MabThera to first line chemotherapy significantly...tzerland (21 May, 2007) _ In a study published,yes...ra (rituximab),plus chemotherapy (MCP*) was shown ... follicular lymphoma (FL) compared to,chemotherapy...pe of,indolent lymphoma, a slow progressing but in...
...elease of Data for New Combination, PARSIPPANY, N....cium channel blocker amlodipine besylate with the ... produced significant mean,reductions in seated sy...th hypertension, according to data presented at th... Annual Scientific,Meeting and Exposition (ASH 200...
Other Medicine Technology:Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 2Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 3Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 4Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3